Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Aug-Oct;19(1-2):135-41.
doi: 10.1007/s12031-002-0024-4.

Calpain inhibitors: a treatment for Alzheimer's disease

Gabriella Di Rosa  1 , Tatjana Odrijin, Ralph A Nixon, Ottavio Arancio
Affiliations

Calpain inhibitors: a treatment for Alzheimer's disease

Gabriella Di Rosa et al. J Mol Neurosci. 2002 Aug-Oct.

Abstract

Activation of the calpain system might contribute to the impairment of synaptic transmission in Alzheimer's disease (AD) (Liu et al., 1999; Rapoport, 1999; Selkoe, 1994). Calpains regulate the function of many proteins by limited proteolysis and initiate the complete degradation of other proteins. In particular, they modulate processes that govern the function and metabolism of proteins key to the pathogenesis of AD, including tau and amyloid precursor protein (APP). (Xie and Johnson, 1998; Wang, 2000). We have found that overexpression of APP(K670M:N671L) and PS1(M146L) proteins in hippocampal cultures derived from transgenic mice causes an increase in the frequency of spontaneous release of neurotransmitter. We have also found that calpain immunoreactive clusters are co-localized with immunoreactivity for the vesicle-associated presynaptic marker, synaptophysin. Moreover, application of calpain inhibitor reduces the frequency of spontaneous release of neurotransmitter. Therefore, we have hypothesized that calpains might contribute to the increase in transmitter release. Based on this hypothesis, we propose to test whether it is possible to restore normal synaptic transmission between cells derived from the transgenic model of AD by using calpain inhibitors. The transgenic mouse model also shows spatial learning impairment, a phenomenon that is thought to be associated with plastic changes at synaptic level. Therefore, we will also test whether we can rescue the learning impairment through a treatment with calpain inhibitors.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Science. 1996 Oct 4;274(5284):99-102 - PubMed
    1. Synapse. 1988;2(1):79-88 - PubMed
    1. Ann N Y Acad Sci. 1994 Dec 15;747:77-91 - PubMed
    1. Nat Med. 1998 Jan;4(1):97-100 - PubMed
    1. Proc Natl Acad Sci U S A. 1984 Jun;81(11):3572-6 - PubMed

Publication types

MeSH terms

LinkOut - more resources